• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索为苏格兰电子轻症服务中执业药师的实践和表现提供反馈的机会。

Exploring opportunities for providing pharmacists with feedback on their practice and performance around the electronic Minor Ailments Service in Scotland.

作者信息

Paudyal Vibhu, Hansford Denise, Cunningham Scott, Stewart Derek

机构信息

School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen, UK.

出版信息

Int J Pharm Pract. 2014 Oct;22(5):319-26. doi: 10.1111/ijpp.12088. Epub 2014 Jan 14.

DOI:10.1111/ijpp.12088
PMID:24423237
Abstract

BACKGROUND

The electronic Minor Ailments Service (e-MAS), implemented in all community pharmacies in Scotland since 2006, allows pharmacists to manage minor ailments at no charge to patients including provision of medication, advice or referral. E-MAS is supported through an electronic network, 'E-pharmacy', which is managed by National Health Service Scotland. E-pharmacy has the capacity to remotely record e-MAS activities, such as details of medicines supply and patient registration allowing provision of feedback to community pharmacies.

OBJECTIVE

The aim of this research was to explore community pharmacists' views on potential utility of e-MAS performance data as a source of feedback on the quality of their own practice.

METHOD

Focus groups and telephone interviews with community pharmacists from four geographical Health Board areas in Scotland were utilised.

KEY FINDINGS

Twenty community pharmacists took part in the study. Pharmacists highlighted potential for feedback to support practice in areas related to medicines supply (for example, formulary adherence and reimbursements to pharmacies from the Health Boards), patient registration and the impact of the new guidelines on their practice. Participants deemed individualised feedback to be potentially more useful than local or national aggregated data sets. Issues of confidentiality and participants' disinterest in feedback were potential barriers to the use of the data.

CONCLUSIONS

This qualitative study has identified potential benefits of performance feedback data to pharmacists' practice. Key barriers to the use of the feedback, such as the issues of privacy and confidentiality need to be addressed by National Health Service information providers. Findings warrant further large scale evaluation of their application to practice.

摘要

背景

自2006年起在苏格兰所有社区药房实施的电子小病服务(e-MAS),允许药剂师免费为患者处理小病,包括提供药物、建议或转诊。e-MAS通过一个由苏格兰国民保健服务局管理的电子网络“电子药房”提供支持。电子药房有能力远程记录e-MAS活动,如药品供应细节和患者登记情况,从而为社区药房提供反馈。

目的

本研究的目的是探讨社区药剂师对e-MAS绩效数据作为其自身业务质量反馈来源的潜在效用的看法。

方法

采用焦点小组和电话访谈的方式,对来自苏格兰四个地理区域卫生委员会地区的社区药剂师进行调查。

主要发现

20名社区药剂师参与了该研究。药剂师强调了反馈在支持药品供应相关领域(例如,药品目录依从性以及卫生委员会对药房的报销)、患者登记以及新指南对其业务的影响等方面业务的潜力。参与者认为个性化反馈可能比本地或全国汇总数据集更有用。保密性问题以及参与者对反馈缺乏兴趣是使用这些数据的潜在障碍。

结论

这项定性研究确定了绩效反馈数据对药剂师业务的潜在益处。国民保健服务信息提供者需要解决使用反馈的关键障碍,如隐私和保密问题。研究结果值得对其在实践中的应用进行进一步大规模评估。

相似文献

1
Exploring opportunities for providing pharmacists with feedback on their practice and performance around the electronic Minor Ailments Service in Scotland.探索为苏格兰电子轻症服务中执业药师的实践和表现提供反馈的机会。
Int J Pharm Pract. 2014 Oct;22(5):319-26. doi: 10.1111/ijpp.12088. Epub 2014 Jan 14.
2
Cross-sectional survey of community pharmacists' views of the electronic Minor Ailment Service in Scotland.苏格兰社区药剂师对电子小病服务看法的横断面调查。
Int J Pharm Pract. 2010 Aug;18(4):194-201. doi: 10.1111/j.2042-7174.2010.00042.x.
3
How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives.如何提高社区药房的公共卫生服务利用率?:普通公众和卫生服务提供者的观点。
Res Social Adm Pharm. 2014 Mar-Apr;10(2):272-84. doi: 10.1016/j.sapharm.2012.05.006. Epub 2012 Oct 23.
4
Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.在英国实施新医药服务之前,社区药剂师和首席药剂师对该服务的看法和经验。
Res Social Adm Pharm. 2014 Jan-Feb;10(1):58-71. doi: 10.1016/j.sapharm.2013.03.003. Epub 2013 Apr 19.
5
A qualitative study exploring community pharmacists' awareness of, and contribution to, self-care support in the management of long-term conditions in the United Kingdom.一项定性研究,探讨英国社区药剂师对长期病症管理中自我护理支持的认识及贡献。
Res Social Adm Pharm. 2015 Nov-Dec;11(6):859-79. doi: 10.1016/j.sapharm.2014.12.010. Epub 2015 Jan 12.
6
Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.在社区药房推广体重管理服务:苏格兰药房团队的观点
Int J Clin Pharm. 2015 Aug;37(4):599-606. doi: 10.1007/s11096-015-0102-7. Epub 2015 Mar 31.
7
Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.苏格兰不同治疗领域新分类药物在实践中的采用:与决策相关因素的定量研究。
Res Social Adm Pharm. 2014 Jan-Feb;10(1):88-105. doi: 10.1016/j.sapharm.2013.04.007. Epub 2013 May 10.
8
A qualitative exploration of opinions on the community pharmacists' role amongst the general public in Scotland.对苏格兰公众对社区药剂师角色看法的定性探索。
Int J Pharm Pract. 2013 Oct;21(5):288-96. doi: 10.1111/ijpp.12008. Epub 2012 Nov 22.
9
Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project.在社区连锁药房实践中实施针对性药物依从性干预措施:宾夕法尼亚项目。
J Am Pharm Assoc (2003). 2014 Nov-Dec;54(6):584-93. doi: 10.1331/JAPhA.2014.14034.
10
Community pharmacists' experience and perceptions of the New Medicines Service (NMS).社区药剂师对新药品服务(NMS)的经验与看法。
Int J Pharm Pract. 2015 Dec;23(6):399-406. doi: 10.1111/ijpp.12180. Epub 2015 Feb 25.

引用本文的文献

1
Ethical and legal considerations governing use of health data for quality improvement and performance management: a scoping review of the perspectives of health professionals and administrators.关于将健康数据用于质量改进和绩效管理的伦理与法律考量:对卫生专业人员和管理人员观点的范围界定审查
BMJ Open Qual. 2025 Apr 17;14(2):e003309. doi: 10.1136/bmjoq-2025-003309.